Valley National Advisers Inc Abiomed Inc Transaction History

Valley National Advisers Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$242.49 - $301.46 $5,577 - $6,933	-23 Reduced 57.5%	17 $4,000
Q2 2022 Jul 15, 2022	BUY	$224.73 - $338.64 $449 - $677	2 Added 5.26%	40 $11,000
Q1 2022 May 06, 2022	BUY	$277.25 - $366.29 $2,772 - $3,662	10 Added 35.71%	38 $13,000
Q4 2021 Feb 11, 2022	SELL	$300.63 - $371.35 $1,503 - $1,856	-5 Reduced 15.15%	28 $10,000
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $930 - $1,128	3 Added 10.0%	33 $11,000
Q2 2021 Aug 02, 2021	BUY	$262.71 - $351.17 $1,576 - $2,107	6 Added 25.0%	30 $9,000
Q1 2021 May 07, 2021	BUY	$285.92 - $355.13 $2,001 - $2,485	7 Added 41.18%	24 $8,000
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $4,727 - $7,585	17 New	17 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.